Home › NDC Lookup › RxCUI directory › RxCUI 1092428

Diphenhydramine hydrochloride 20 MG/ML / zinc acetate 1 MG/ML Topical Cream [Banophen Crea... — RxCUI 1092428

RxNorm drug concept · Semantic branded drug
RxCUI 1092428 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1092428
Official nameDiphenhydramine hydrochloride 20 MG/ML / zinc acetate 1 MG/ML Topical Cream [Banophen Cream]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asBanophen Cream (diphenhydramine hydrochloride 2 % / zinc acetate 0.1 % ) Topical Cream; Banophen Cream 2 % / 0.1 % Topical Cream
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)777 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Diphenhydramine Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • You can use it for temporary relief of pain and itching from everyday skin problems — things like insect bites, minor burns, minor cuts and scrapes, and general skin irritations. I...
  • What can I actually use this cream or spray for?
  • You can apply it up to 3 to 4 times a day, but no more than that. More frequent use isn't going to help more — and the label is clear that you shouldn't exceed that limit. For kids...
  • This is really important — do not use this topical product at the same time as any other product that contains diphenhydramine, even a pill or capsule. That includes allergy medici...
📖 Read our full Diphenhydramine Topical guide →

🕸️ Concept Web — How Diphenhydramine hydrochloride 20 MG/ML / zinc ac... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Diphenhydramine hydrochloride 20 MG/ML / zinc acetate 1 MG/ML Topical Cream [Banophen Cream] RxCUI 1092428

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Diphenhydramine 3498
    • Zinc acetate 58295
    • Diphenhydramine / zinc acetate 466522
    • Diphenhydramine hydrochloride 1362
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Banophen Cream 1092425
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Diphenhydramine / zinc acetate Topical Cream 377686
    • Diphenhydramine hydrochloride / zinc acetate Topical Cream 2647537
    • Diphenhydramine / zinc acetate Topical Product 1158436
    • Diphenhydramine hydrochloride / zinc acetate Topical Product 2659163
    • Diphenhydramine / zinc acetate Topical Cream [Banophen Cream] 1092427
    • Diphenhydramine hydrochloride / zinc acetate Topical Cream [Banophen Cream] 2654898
    • Banophen Cream Topical Product 1167996
    • Topical Cream 316982
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 17 of 18 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Diphenhydramine hydrochloride 20 MG/ML / zinc acetate 1 MG/ML Topical Cream SCD · 1087026
  • Diphenhydramine hydrochloride 20 MG/ML SCDC · 1049097
  • Zinc acetate 1 MG/ML SCDC · 340184
  • Diphenhydramine / zinc acetate Topical Cream SCDF · 377686
  • Diphenhydramine hydrochloride / zinc acetate Topical Cream SCDFP · 2647537
  • Diphenhydramine / zinc acetate Topical Product SCDG · 1158436
  • Diphenhydramine hydrochloride / zinc acetate Topical Product SCDGP · 2659163

Brand-Name Concepts

  • Diphenhydramine hydrochloride 20 MG/ML / zinc acetate 1 MG/ML [Banophen Cream] SBDC · 1092426
  • Diphenhydramine / zinc acetate Topical Cream [Banophen Cream] SBDF · 1092427
  • Diphenhydramine hydrochloride / zinc acetate Topical Cream [Banophen Cream] SBDFP · 2654898
  • Banophen Cream Topical Product SBDG · 1167996
  • Banophen Cream BN · 1092425

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1092428 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00904-5354-31 1 TUBE in 1 CARTON (0904-5354-31) / 28 g in 1 TUBE Banophen Major Pharmaceuticals 2009-06-19
Observed labelers: Major Pharmaceuticals (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$0.0581
Range $0.0581–$0.0581 · middle 50% $0.0581–$0.0581 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.